Metall Zug (FRA:NDH1) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:NDH1 Metall Zug Ltd FRA:NDH1
62 GF Score
Price €800.00
GF Value €794.29
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Metall Zug FFO per Share?

FFO per Share only applies to REITs.

FRA:NDH1
62GF Score
Metall Zug Ltd FRA:NDH1
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Metall Zug (FRA:NDH1) Overvalued in 2026?

Based on GuruFocus' analysis, Metall Zug stock appears to be overvalued. The current stock price of €800.00 is trading 0.7% above its estimated GF Value™ of €794.29. GuruFocus considers Metall Zug to be Fairly Valued.

Key valuation signals for FRA:NDH1:

  • FFO per Share:
  • GF Value™: €794.29 vs. price of €800.00 (0.7% above fair value)
  • GF Score™: 62/100 with 4 warning signs

No single metric tells the full story. See the FRA:NDH1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Metall Zug Business Description

Other Exchanges 0QLX:UKMETN:Switzerland
Address Industriestrasse 66, Zug, CHE, 6302
Metall Zug Ltd is engaged in the industrial sector. The company is organized, into business segments namely; Medical Devices which comprises of products and services for diagnosis and surgery, mainly in the fields of ophthalmology and microsurgery; Technologycluster & Infrastructure is engaged in Management and development of real estate; and Investments & Corporate. The majority of its revenue is generated from the Medical Devices segment. Geographically, the company operates in Switzerland, Europe (excluding Switzerland), the Americas, and Asia /Pacific/Others, and the majority of its revenue is generated from the Americas region.
62GF Score

Get the complete analysis for FRA:NDH1

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€800.00
Price
€794.29
GF Value